Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epothilone D in Advanced NSCLC
NCT00081107Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2003
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Epothilone D in non-small cell lung cancer (NSCLC), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Objective Response Rate. Started Dec 2003; status: completed.
02
Drugs
Epothilone D
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00081107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081107.